The results showed that a higher expression level of TAF15 was identified in high T stage GC patients (Fig. 2c), while there was no significant difference in pathologic stage (Fig. 2d), N stage (Fig. 2e) or M stage (Fig. 2f). Here, TAF15 is linked to gastric cancer.